Andere Kunden interessierten sich auch für
![Neurodegenerative Diseases]( "Neurodegenerative Diseases")
Neurodegenerative Diseases91,99 €![Genetics of Alzheimer's Disease]( "Genetics of Alzheimer's Disease")
Genetics of Alzheimer's Disease52,99 €![Calcium Signalling in Alzheimer's Disease]( "Calcium Signalling in Alzheimer's Disease")
Calcium Signalling in Alzheimer's Disease58,99 €![Cancer Biomarker Research and Personalized Medicine]( "Cancer Biomarker Research and Personalized Medicine")
Cancer Biomarker Research and Personalized Medicine121,99 €![Recent Advances in Volatile Organic Compound Analysis as Diagnostic Biomarkers]( "Recent Advances in Volatile Organic Compound Analysis as Diagnostic Biomarkers")
Recent Advances in Volatile Organic Compound Analysis as Diagnostic Biomarkers77,99 €![Cancer Biomarkers in Body Fluids]( "Cancer Biomarkers in Body Fluids")
Cancer Biomarkers in Body Fluids143,99 €![New Insights into the Diagnosis and Treatment of Temporomandibular Joint Diseases]( "New Insights into the Diagnosis and Treatment of Temporomandibular Joint Diseases")
New Insights into the Diagnosis and Treatment of Temporomandibular Joint Diseases75,99 €
Alzheimer's disease (AD) represents the most common form of dementia in the elderly population worldwide. AD is characterized by progressive neurodegeneration that leads to a gradual deterioration of memory and other cognitive functions. Given the global prevalence and impact of AD, there is a critical need to establish biomarkers that can be used to detect AD in individuals before the onset of clinical signs and provide mitigating therapeutics. The aim of this Special Issue is to discuss the current knowledge as well as future perspectives on the role of biomarkers in the screening, diagnosis, treatment and follow-up of AD.